Atezolizumab Trial in Endometrial Cancer - AtTEnd
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Endometrial Cancer
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03603184
- Collaborators
- Hoffmann-La Roche
- Investigators
- Principal Investigator: Nicoletta Colombo, MD Istituto Europeo di Oncologia (IEO) - Milan